NBP-603

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameNBP-603

Drug Alias NameNBP-603

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor

Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulantsBlood coagulation pathway activation

TargetsCoagulation factor X

Therapy Area/IndicationsHemophilia A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesSk Chemicals

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSk Chemicals

Active IndicationsN/A

Inactive IndicationsHemophilia A

ATC CodeN/A